White & Case advised Apollomics Inc., while Nelson Mullins Riley & Scarborough and Harneys represented Maxpro on the deal. Apollomics Inc., a late-stage clinical biopharmaceutical company,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
